Tudor Gold Announces Closing of $11.5 Million Brokered LIFE Offering, with Participation by Eric Sprott
aTyr PharmaaTyr Pharma(US:LIFE) TMX Newsfile·2025-12-15 15:45

Core Viewpoint - Tudor Gold Corp. has successfully closed a private placement offering, raising a total of $11.5 million through the sale of 14,375,000 units at a price of $0.80 per unit, including the full exercise of the over-allotment option [1]. Group 1: Offering Details - Each unit consists of one common share and one-half of a common share purchase warrant, with each whole warrant allowing the purchase of one common share at an exercise price of $1.20 for 24 months [2]. - The offering was completed under the Listed Issuer Financing Exemption, allowing the units to be free-trading upon closing under Canadian securities laws [3]. - The net proceeds from the offering will be allocated for working capital and general corporate purposes [3]. Group 2: Related Party Transactions - A related party acquired 2,500,000 common shares and 1,250,000 warrants as part of the offering, which is classified as a related party transaction [4]. - The company relied on exemptions from valuation and minority shareholder approval requirements, as the fair market value of the securities issued does not exceed 25% of the company's market capitalization [4]. Group 3: Agent Compensation - The company paid approximately $690,000 in cash commissions to the agents and issued 750,000 non-transferable broker warrants, each allowing the purchase of one common share at an exercise price of $1.20 for 24 months [5]. - The offering is subject to final approval from the TSX Venture Exchange [5]. Group 4: Company Overview - Tudor Gold is engaged in the exploration and development of precious and base metals, with claims in British Columbia's Golden Triangle, an area known for its mining potential [7].

aTyr Pharma-Tudor Gold Announces Closing of $11.5 Million Brokered LIFE Offering, with Participation by Eric Sprott - Reportify